Prevalence and Risk Factors for COPD in an Urbanizing Rural Area in Western China: A Cross-Sectional Study

References

• WHO’s Global Health Estimates. The top 10 causes of death. Available from: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death. Accessed January 12, 2021.
   Google Scholar
• Wang C, Xu J, Yang L, et al. Prevalence and risk factors of chronic obstructive pulmonary disease in China (the China Pulmonary Health [CPH] study): a national cross-sectional study. Lancet. 2018;391(10131):1706–1717. doi:10.1016/S0140-6736(18)30841-9
   PubMed Web of Science ®Google Scholar
• IHME. What causes the most death and disability combined? Available from: http://www.healthdata.org/china. Accessed November 1, 2021.
   Google Scholar
• Zhu B, Wang Y, Ming J, Wen C, Zhang L. Disease burden of COPD in China: a systematic review. Int J Chron Obstruct Pulmon Dis. 2018;13:1353–1364. doi:10.2147/COPD.S161555
   PubMed Web of Science ®Google Scholar
• IQAir. LIVE AQI city ranking; 2021. Available from: https://www.iqair.cn/cn/world-air-quality-ranking. Accessed December 6, 2021.
   Google Scholar
• Pan Z, Dichens AP, Chi C, et al. Study to evaluate the effectiveness and cost-effectiveness of different screening strategies for identifying undiagnosed COPD among residents (≥40 years) in four cities in China: protocol for a multicentre cross-sectional study on behalf of the Breathe Well group. BMJ Open. 2020;10:e035738. doi:10.1136/bmjopen-2019-035738
   PubMed Web of Science ®Google Scholar
• Fleiss JL, Leivin B, Paik M. Statistical Methods for Rates and Proportions. 3rd ed. John Wiley & Sons; 2003.
   Google Scholar
• Newcombe R. Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med. 1998;17(8):857–872. doi:10.1002/(sici)1097-0258(19980430)17:8<857::aid-sim777>3.0.co;2-e
   PubMed Web of Science ®Google Scholar
• Global Initiative for Chronic Obstructive Lung Disease (GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease; 2020. Available from: https://goldcopd.org/wp-content/uploads/2019/12/GOLD-2020-FINAL-ver1.2-03Dec19_WMV.pdf. Accessed November 15, 2019.
   Google Scholar
• Zhou L, Jiang Y, Du C, et al. Development of an internet-of-things based portable spirometer and the validation of its accuracy (in Chinese). Int J Respir. 2019;39(2):113–118. doi:10.3760/cma.j.issn.1673-436X.2019.02.007
   Google Scholar
• China Methology Association, ATC 17. Calibration specification for the pulmonary function measuring instrument. In: General Administration of Quality Supervision, Inspection and Quarantine of the People’s Republic of China. Beijing, China: China Methology Association; 2009.
   Google Scholar
• Miller MR, Hankinson J, Brusasco V, et al. Standardisation of spirometry. Eur Respir J. 2005;26(2):319–338. doi:10.1183/09031936.05.00034805
   PubMed Web of Science ®Google Scholar
• Gerbase M, Dupuis-Lozeron E, Schindler C, Keidel D, Künzli N. Agreement between spirometers a challenge in the follow-up of patients and populations? Respiration. 2013;85(6):505–514. doi:10.1159/000346649
   PubMed Web of Science ®Google Scholar
• Yan X, Xu L, Shi B, Wang H, Xu X, Xu G. Epidemiology and risk factors of chronic obstructive pulmonary disease in Suzhou: a population-based cross-sectional study. J Thorac Dis. 2020;12(10):5347–5356. doi:10.21037/jtd-20-1616
   PubMed Web of Science ®Google Scholar
• He M, Zeng X, Zhang K, Kinney PL. Fine particulate matter concentrations in urban Chinese cities, 2005–2016: a systematic review. Int J Environ Res Public Health. 2017;14:191. doi:10.3390/ijerph14020191
   PubMed Web of Science ®Google Scholar
• Guan WJ, Zheng XY, Chung KF, Zhong NS. Impact of air pollution on the burden of chronic respiratory diseases in China: time for urgent action. Lancet. 2016;388(10054):1939–1951. doi:10.1016/S0140-6736(16)31597-5
   PubMed Web of Science ®Google Scholar
• Liu S, Zhou Y, Liu S, et al. Association between exposure to ambient particulate matter and chronic obstructive pulmonary disease: results from a cross-sectional study in China. Thorax. 2017;72(9):788–795. doi:10.1136/thoraxjnl-2016-208910
   PubMed Web of Science ®Google Scholar
• Zhong N, Wang C, Yao W, et al. Prevalence of chronic obstructive pulmonary disease in China: a large, population-based survey. Am J Respir Crit Care Med. 2007;176(8):753–760. doi:10.1164/rccm.200612-1749OC
   PubMed Web of Science ®Google Scholar
• Foreman MG, Zhang L, Murphy J, et al. Early-onset chronic obstructive pulmonary disease is associated with female sex, maternal factors, and African American race in the COPD gene study. Am J Respir Crit Care Med. 2011;184(4):414–420. doi:10.1164/rccm.201011-1928OC
   PubMed Web of Science ®Google Scholar
• Landis SH, Mannino H, Mannino DM, Menezes AM, Davis JK. Continuing to confront COPD international patient survey: methods, COPD prevalence, and disease burden in 2012–2013. Int J Chron Obstruct Pulmon Dis. 2014;9:597–611. doi:10.2147/COPD.S61854
   PubMed Web of Science ®Google Scholar
• Hagstad S, Bjerg A, Ekerljung L, et al. Passive smoking exposure is associated with increased risk of COPD in never smokers. Chest. 2014;145(6):1298–1304. doi:10.1378/chest.13-1349
   PubMed Web of Science ®Google Scholar
• Sana A, Somda S, Meda N, Bouland C. Chronic obstructive pulmonary disease associated with biomass fuel use in women: a systematic review and meta-analysis. BMJ Open Respir Res. 2018;5(1):e000246. doi:10.1136/bmjresp-2017-000246
   PubMed Web of Science ®Google Scholar
• Bird Y, Moraros J, Mahmood R, Esmaeelzadeh S, Soe N. Prevalence and associated factors of COPD among aboriginal peoples in Canada: a cross- sectional study. Int J COPD. 2017;12:1915–1922. doi:10.2147/COPD.S138304
   Google Scholar
• Grigsby M, Siddharthan T, Chowdhury MA, et al. Socioeconomic status and COPD among low- and middle-income countries. Int J Chron Obstruct Pulmon Dis. 2016;11:2497–2507. doi:10.2147/COPD.S111145
   PubMed Web of Science ®Google Scholar
• Fan JW, Wang N, Fang LW, Feng YJ, Wang BH. Awareness of knowledge about chronic obstructive pulmonary disease and related factors in residents aged 40 years and older in China, 2014. Chin J Epidemiol. 2018;39(5):586–592. doi:10.3760/cma.j.issn.0254-6450.2018.05.009
   Google Scholar
• Zhou Y, Wang C, Yao W, et al. COPD in Chinese nonsmokers. Eur Respir J. 2009;33:509–518. doi:10.1183/09031936.00084408
   PubMed Web of Science ®Google Scholar
• Guillien A, Puyraveau M, Soumagne T, et al. Prevalence and risk factors for COPD in farmers: a cross-sectional controlled study. Eur Respir J. 2016;47(1):95–103. doi:10.1183/13993003.00153-2015
   PubMed Web of Science ®Google Scholar
• Landbo C, Prescott E, Lange P, Vestbo J, Almdal TP. Prognostic value of nutritional status in chronicobstructive pulmonary disease. Am J Respir Crit Care Med. 1999;160(6):1856–1861. doi:10.1164/ajrccm.160.6.9902115
   PubMed Web of Science ®Google Scholar
• Guo Y, Zhang T, Wang Z, et al. Body mass index and mortality in chronic obstructive pulmonary disease: a dose-response meta-analysis. Medicine. 2016;95(28):e4225. doi:10.1097/MD.0000000000004225
   PubMed Web of Science ®Google Scholar
• Brigham EP, Anderson JA, Brook RD, et al. Challenging the obesity paradox: extreme obesity and COPD mortality in the SUMMIT trial. ERJ Open Res. 2021;7(3):00902–2020. doi:10.1183/23120541.00902-2020
   PubMedGoogle Scholar
• Hanson C, LeVan T. Obesity and chronic obstructive pulmonary disease: recent knowledge and future directions. Curr Opin Pulm Med. 2017;23(2):149–153. doi:10.1097/MCP.0000000000000354
   PubMed Web of Science ®Google Scholar
• Vestbo J, Prescott E, Almdal T, et al. Body mass, fat-free body mass, and prognosis in patients with chronic obstructive pulmonary disease from a random population sample: findings from the Copenhagen city heart study. Am J Respir Crit Care Med. 2006;173(1):79–83. doi:10.1164/rccm.200506-969OC
   PubMed Web of Science ®Google Scholar
• Siu AL, Bibbins-Domingo K, Grossman DC; US Preventive Task Force. Screening for chronic obstructive pulmonary disease: US preventive services task force recommendation statement. JAMA. 2016;315(13):1372–1377. doi:10.1001/jama.2016.2638
   PubMed Web of Science ®Google Scholar
• Bhatt SP, O’Conner GT. Screening for chronic obstructive pulmonary disease challenges and opportunities. JAMA. 2022;19(8):1267–1274. doi:10.1001/jama.2022.3823
   Google Scholar
• Fortis S. Should we consider screening spirometry in individuals who are “asymptomatic”? Ann Am Thorac Soc. 2022;19(8):1268–1269. doi:10.1513/AnnalsATS.202205-374ED
   PubMed Web of Science ®Google Scholar
• Bednarek M, Maciejewski J, Wozniak M, Kuca P, Zielinski J. Prevalence, severity and un-derdiagnosis of COPD in the primary care setting. Thorax. 2008;63(5):402–407. doi:10.1136/thx.2007.085456
   PubMed Web of Science ®Google Scholar
• Mapel DW, Dalal AA, Blanchette CM, Petersen H, Ferguson G. Severity of COPD at initial spirometry-confirmed diagnosis: data from medical charts and administrative claims. Int J Chron Obstruct Pulmon Dis. 2016;6:573–581. doi:10.2147/COPD.S16975
   Google Scholar